Nonradiological Treatment for Liver Tumors

  • Shiva Jayaraman
  • Yuman Fong


Historically, liver resection was associated with high operative morbidity as well as high perioperative mortality rates [1]. There was a routine need for blood transfusion due to high operative blood loss. Advances in surgical techniques, an increased understanding of the importance of low central venous pressure anesthesia to minimize bleeding, and improved perioperative care have resulted in reduced morbidity and very low operative mortality rates even with extensive liver resections [2, 3].


Liver Resection Metastatic Colorectal Cancer Portal Vein Embolization Future Liver Remnant Extrahepatic Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Pawlik TM, Scoggins CR, Thomas MB, Vauthey JN. Advances in the surgical management of liver malignancies. Cancer J. 2004;10(2):74–87.PubMedCrossRefGoogle Scholar
  2. 2.
    Blumgart LH. Resection of the liver. J Am CollSurg. 2005;201(4):492–4.CrossRefGoogle Scholar
  3. 3.
    Fong Y, Blumgart LH, Cohen AM. Surgical treatment of colorectal metastases to the liver. CA Cancer J Clin. 1995;45(1):50–62.PubMedCrossRefGoogle Scholar
  4. 4.
    Charny CK, Jarnagin WR, Schwartz LH, et al. Management of 155 patients with benign liver tumours. Br J Surg. 2001;88(6):808–13.PubMedCrossRefGoogle Scholar
  5. 5.
    Colli A, Fraquelli M, Massironi S, et al. Elective surgery for benign liver tumours. Cochrane Database Syst Rev 2007(1):CD005164.Google Scholar
  6. 6.
    Nagorney DM. Benign hepatic tumors: focal nodular hyperplasia and hepatocellular adenoma. World J Surg. 1995;19(1):13–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Vandeweyer D, Neo EL, Chen JW, et al. Influence of resection margin on survival in hepatic resections for colorectal liver metastases. HPB (Oxford). 2009;11(6):499–504.CrossRefGoogle Scholar
  8. 8.
    Are C, Gonen M, Zazzali K, et al. The impact of margins on outcome after hepatic resection for colorectal metastasis. Ann Surg. 2007;246(2):295–300.PubMedCrossRefGoogle Scholar
  9. 9.
    Muratore A, Ribero D, Zimmitti G, Mellano A, Langella S, Capussotti L. Resection margin and recurrence-free survival after liver resection of colorectal metastases. Ann Surg Oncol. 2010;17(5):1324–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Zorzi D, Mullen JT, Abdalla EK, et al. Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases. J Gastrointest Surg. 2006;10(1):86–94.PubMedCrossRefGoogle Scholar
  11. 11.
    Esnaola N, Vauthey JN, Lauwers G. Liver fibrosis increases the risk of intrahepatic recurrence after hepatectomy for hepatocellular carcinoma. Br J Surg. 2002;89(7):939–40. author reply 940.PubMedCrossRefGoogle Scholar
  12. 12.
    Bilimoria MM, Lauwers GY, Doherty DA, et al. Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma. Arch Surg. 2001;136(5):528–35.PubMedCrossRefGoogle Scholar
  13. 13.
    Blumgart LH, Leach KG, Karran SJ. Observations on liver regeneration after right hepatic lobectomy. Gut. 1971;12(11):922–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Makuuchi M, Thai BL, Takayasu K, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery. 1990;107(5):521–7.PubMedGoogle Scholar
  15. 15.
    Covey AM, Tuorto S, Brody LA, et al. Safety and efficacy of preoperative portal vein embolization with polyvinyl alcohol in 58 patients with liver metastases. AJR Am J Roentgenol. 2005;185(6):1620–6.PubMedCrossRefGoogle Scholar
  16. 16.
    Couinaud C. Anatomic principles of left and right regulated hepatectomy: technics. J Chir (Paris). 1954;70(12):933–66.Google Scholar
  17. 17.
    Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. European Association for the Study of the Liver. J Hepatol. 2001;35(3):421–30.PubMedCrossRefGoogle Scholar
  18. 18.
    Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg. 1964;1:1–85.PubMedGoogle Scholar
  19. 19.
    Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60(8):646–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Ribero D, Abdalla EK, Thomas MB, Vauthey JN. Liver resection in the treatment of hepatocellular carcinoma. Expert Rev Anticancer Ther. 2006;6(4):567–79.PubMedCrossRefGoogle Scholar
  21. 21.
    Poon RT, Fan ST, Lo CM, et al. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg. 2002;235(3):373–82.PubMedCrossRefGoogle Scholar
  22. 22.
    Cherqui D, Laurent A, Mocellin N, et al. Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation. Ann Surg. 2009;250(5):738–46.PubMedCrossRefGoogle Scholar
  23. 23.
    Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334(11):693–9.PubMedCrossRefGoogle Scholar
  24. 24.
    Mazzaferro V, Llovet JM, Miceli R, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol. 2009;10(1):35–43.PubMedCrossRefGoogle Scholar
  25. 25.
    Llovet JM, Bruix J, Fuster J, et al. Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power. Hepatology. 1998;27(6):1572–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Fuster J, Charco R, Llovet JM, Bruix J, García-Valdecasas JC. Liver transplantation in hepatocellular carcinoma. Transpl Int. 2005;18(3):278–82.PubMedCrossRefGoogle Scholar
  27. 27.
    Llovet JM, Bruix J. Molecular targeted therapies in hepatocellular carcinoma. Hepatology. 2008;48(4):1312–27.PubMedCrossRefGoogle Scholar
  28. 28.
    Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359(4):378–90.PubMedCrossRefGoogle Scholar
  29. 29.
    Taylor R, Fong Y. Surgical treatment of hepatic metastases from colorectal cancer. In: Blumgart LH, editor. Surgery of the liver, biliary tract, and pancreas, vol. 2. Philadelphia: Saunders; 2007. p. 1178–9.Google Scholar
  30. 30.
    Carpizo DR, Are C, Jarnagin W, et al. Liver resection for metastatic colorectal cancer in patients with concurrent extrahepatic disease: results in 127 patients treated at a single center. Ann Surg Oncol. 2009;16(8):2138–46.PubMedCrossRefGoogle Scholar
  31. 31.
    DeMatteo RP, Palese C, Jarnagin WR, Sun RL, Blumgart LH, Fong Y. Anatomic segmental hepatic resection is superior to wedge resection as an oncologic operation for colorectal liver metastases. J Gastrointest Surg. 2000;4(2):178–84.PubMedCrossRefGoogle Scholar
  32. 32.
    Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230(3):309–18. discussion 318–21.PubMedCrossRefGoogle Scholar
  33. 33.
    Allen PJ, Kemeny N, Jarnagin W, et al. Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J Gastrointest Surg. 2003;7(1):109–15. discussion 116–7.PubMedCrossRefGoogle Scholar
  34. 34.
    Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet. 2008;371(9617):1007–16.PubMedCrossRefGoogle Scholar
  35. 35.
    Kemeny NE, Melendez FD, Capanu M, et al. Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma. J Clin Oncol. 2009;27(21):3465–71.PubMedCrossRefGoogle Scholar
  36. 36.
    House MG, Kemeny N, Jarnigin W, et al. Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer. In: Proceedings from the American Society of Clinical Oncology Gastrointestinal Cancers Symposium; 2009 Jan 15–17; San Francisco, California. Abstract 383.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Department of SurgeryMemorial Sloan-Kettering Cancer CenterNew YorkUSA

Personalised recommendations